Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 146 results for "ajanta pharma"

Re-fixing ceiling prices: NPPA asks pharma companies to submit sales data
Indian Express

Ajanta Pharma spurts on receiving USFDA approval for Duloxetin...

India, Jan. 10 -- Ajanta Pharma is currently trading at Rs 1800.00, up by 25.90 points or 1.46% from its previous closing of Rs. 1774.10 on the BSE.The scrip opened at Rs. 1804.00 and has touched a high and low of Rs. 1819.75 and Rs. 1793.20 ... HT Syndication, 1 week ago
Ajanta Pharma: USFDA nod adds strength Business Line, 1 week ago

37 images for ajanta pharma

Business Standard India, 1 week ago
Yahoo! Singapore, 2 months ago
WorldNetDaily, 2 months ago
PharmaVOICE, 2 months ago
Yahoo! Finance, 2 months ago
New Indian Express, 1 month ago
BioSpace, 2 months ago
PR Newswire, 2 months ago
WorldNetDaily, 2 months ago
Yahoo! Finance, 2 months ago

Ajanta Pharma informs about board meeting

A dedicated place to get a comprehensive economic update, Interactive tools and to voice your opinions. News pertaining to Markets, Corporates, Industry, Economy, Mutual Fund and Business RBI Policy Indicators, Exchange Rates and General ...
 Finalaya.com4 days ago Betting on second-line pharma companies: Dipan Mehta  Economic Times1 month ago Ajanta Pharma to pay interim dividend  Business Standard2 months ago Ajanta Pharma declares interim dividend  Money Control2 months ago

Ajanta Pharma to announce Q3 results

On 24 January 2017
 Business Standard3 days ago Ajanta Pharma Ltd to consider Q3 results on Jan 24, 2017  Equity Bulls2 days ago PAT up 26%, Income from Operations up 17% in Q2 FY 2017 (2nd Quarter & Half Year, FY 2017 Consolidated Results)  India PRwire2 months ago
Yahoo! Finance

Stocks To Watch: Ajanta Pharma, Max Ventures, Fortis Healthcare And More

Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg's global leadership in business and financial news and data, with Quintillion Media's deep expertise in the Indian market and digital news ...
 Bloomberg-Quint1 week ago Stocks Radar: Ajanta Pharma, Indraprastha Gas, Voltas And More  Bloomberg-Quint2 months ago Ajanta Pharma Announces the Launch of Aripiprazole Tablets  TickerTech.com2 months ago Ajanta Pharma announces launch of Amlodipine- Olmesartan Medoxomil tablets  Money Control2 months ago

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016 (SCRIPCODE: 532331)

Cities Business & Finance ACCORD FINTECH BSE Online News India, Jan. 10 -- Ajanta Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under ...
 HT Syndication1 week ago

Ajanta Pharma Jumps On Drug Nod; Axis Bank Top Loser On Nifty

Shares of the public sector lender rose 0.9 percent to Rs 64 after it slashed its benchmark lending rate by 0.85 percent, in line with market competition. The bank has reduced marginal cost of funds based lending rate to 8.60 percent for 1 year ...
 Bloomberg-Quint1 week ago

Skill Development Council mandates Pollux to upgrade skill-sets in pharma space

Life Science Sector Skill Development Council (LSSSDC), established under the auspices of Ministry of Skill Development has mandated Mumbai-based Pollux to upgrade skill-sets among emerging pharmacists to bridge the industry-academia gap. ...
 PharmaBiz12 hours ago
India Infoline

Pharmaceuticals Newsletter - January 9 to 13, 2017 [India Infoline News Service]

This week, Cadila's subsidiary settled its patent litigation and Aurobindo declared growth prospects for the next 3-4 years. IIFL presents a weekly snapshot of all the major happenings in the Pharmaceuticals industry. Top News Lupin launches ...
 Pharmacy Choice3 days ago 1/13/17 - Pharmaceuticals Newsletter - January 9 to 13, 2017 [India Infoline News Service]  Pharmacy Choice3 days ago
DNA India

Biocon up 3% as USFDA accepts Trastuzumab license application

Biocon Limited bucked the downward trend in the pharma stocks on Thusday and was trading up over 3% in early trade after the US Food and Drug Administration (USFDA) had accepted Mylan's biologics license application for MYL-1401O, a proposed ...
 DNA India5 days ago

Fixed dose combination drugs to be banned or not to be banned

Ajay Bhargava , Vanita Bhargava and Aseem Chaturvedi explain how the FDC ban notification has adversely affected the pharma industry Ajay Bhargava With the advancement of science and technology, the pharmaceutical Industry has also grown and ...
 Express Pharma1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less